Refractory cold agglutinin disease successfully treated with daratumumab. A case report and review of literature
ABSTRACTBackground: Cold agglutinin disease (CAD) is immune-mediated hemolytic anemia. The disease is caused by cold reactive autoantibodies that induce hemolysis through the activation of the complement pathway. Most patients with CAD are elderly, and half may have refractory CAD that may not respo...
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
Taylor & Francis Group
2023-12-01
|
| Edice: | Hematology |
| Témata: | |
| On-line přístup: | https://www.tandfonline.com/doi/10.1080/16078454.2023.2252651 |